Literature DB >> 33745492

Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment.

Ellen Grober1, Cuiling Wang1, Melissa Kitner-Triolo2, Richard B Lipton1, Claudia Kawas3, Susan M Resnick2.   

Abstract

OBJECTIVE: To compare the predictive validity of learning and retention measures from the picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT + IR) for identifying incident mild cognitive impairment (MCI).
METHODS: Learning was defined by the sum of free recall (FR) and retention by delayed free recall (DFR) tested 15-20 min later. Totally, 1422 Baltimore Longitudinal Study of Aging (BLSA) participants (mean age 69.6 years, 54% male, mean 16.7 years of education) without dementia or MCI received the pFCSRT + IR at baseline and were followed longitudinally. Cox proportional hazards models were used to evaluate the effect of baseline learning and retention on risk of MCI.
RESULTS: In total, 187 participants developed MCI over a median of 8.1 years of follow-up. FR and DFR each predicted incident MCI adjusting for age, sex, and education. Also, each independently predicted incident MCI in the presence of the other with similar effect sizes: around 20% decrease in the hazard of MCI corresponding to one standard deviation increase in FR or DFR.
CONCLUSION: The practice of preferring retention over learning to predict incident MCI should be reconsidered. The decision to include retention should be guided by time constraints and patient burden.

Entities:  

Keywords:  Alzheimer’s disease; Free and Cued Selective Reminding Test; Memory disorders; Mild cognitive impairment; Preclinical dementia; Prospective studies; Retention; Verbal learning

Mesh:

Year:  2021        PMID: 33745492      PMCID: PMC8455713          DOI: 10.1017/S1355617721000291

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   3.114


  42 in total

1.  Development of dementing illnesses in an 80-year-old volunteer cohort.

Authors:  R Katzman; M Aronson; P Fuld; C Kawas; T Brown; H Morgenstern; W Frishman; L Gidez; H Eder; W L Ooi
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

2.  On the nature of the memory disorder in presenile dementia.

Authors:  E Miller
Journal:  Neuropsychologia       Date:  1971-03       Impact factor: 3.139

3.  Accelerated forgetting in Alzheimer-type dementia.

Authors:  G J Larrabee; J R Youngjohn; A Sudilovsky; T H Crook
Journal:  J Clin Exp Neuropsychol       Date:  1993-09       Impact factor: 2.475

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study.

Authors:  Mindy J Katz; Richard B Lipton; Charles B Hall; Molly E Zimmerman; Amy E Sanders; Joe Verghese; Dennis W Dickson; Carol A Derby
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

6.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Authors:  K Welsh; N Butters; J Hughes; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1991-03

7.  Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.

Authors:  M W Bondi; D P Salmon; D Galasko; R G Thomas; L J Thal
Journal:  Psychol Aging       Date:  1999-06

8.  Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease.

Authors:  Ellen Grober; Yang An; Richard B Lipton; Claudia Kawas; Susan M Resnick
Journal:  J Int Neuropsychol Soc       Date:  2019-08       Impact factor: 2.892

9.  Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.

Authors:  Elizabeth C Mormino; Kathryn V Papp; Dorene M Rentz; Michael C Donohue; Rebecca Amariglio; Yakeel T Quiroz; Jasmeer Chhatwal; Gad A Marshall; Nancy Donovan; Jonathan Jackson; Jennifer R Gatchel; Bernard J Hanseeuw; Aaron P Schultz; Paul S Aisen; Keith A Johnson; Reisa A Sperling
Journal:  Alzheimers Dement       Date:  2017-02-28       Impact factor: 21.566

10.  MRI and MRS predictors of mild cognitive impairment in a population-based sample.

Authors:  Kejal Kantarci; Stephen D Weigand; Scott A Przybelski; Gregory M Preboske; V Shane Pankratz; Prashanthi Vemuri; Matthew L Senjem; Matthew C Murphy; Jeffrey L Gunter; Mary M Machulda; Robert J Ivnik; Rosebud O Roberts; Bradley F Boeve; Walter A Rocca; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Neurology       Date:  2013-06-12       Impact factor: 9.910

View more
  2 in total

1.  Memory markers in the continuum of the Alzheimer's clinical syndrome.

Authors:  Mario A Parra; Clara Calia; Vivek Pattan; Sergio Della Sala
Journal:  Alzheimers Res Ther       Date:  2022-09-30       Impact factor: 8.823

2.  Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial.

Authors:  Aladdin H Shadyab; Andrea Z LaCroix; Howard H Feldman; Christopher H van Dyck; Ozioma C Okonkwo; Steven P Tam; J Kaci Fairchild; Kathleen A Welsh-Bohmer; Genevieve Matthews; Daniel Bennett; Alexandre A Shadyab; Kimberly A Schafer; Rosemary H Morrison; Sean A Kipperman; Jennifer Mason; Donna Tan; Ronald G Thomas; Carl W Cotman; Laura D Baker
Journal:  Alzheimers Dement       Date:  2021-07-23       Impact factor: 16.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.